JP2022516199A5 - - Google Patents

Info

Publication number
JP2022516199A5
JP2022516199A5 JP2021539453A JP2021539453A JP2022516199A5 JP 2022516199 A5 JP2022516199 A5 JP 2022516199A5 JP 2021539453 A JP2021539453 A JP 2021539453A JP 2021539453 A JP2021539453 A JP 2021539453A JP 2022516199 A5 JP2022516199 A5 JP 2022516199A5
Authority
JP
Japan
Prior art keywords
nrg
lveds
lvedd
mammals
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021539453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022516199A (ja
JP7630173B2 (ja
Filing date
Publication date
Priority claimed from CN201911412811.1A external-priority patent/CN111407881A/zh
Application filed filed Critical
Publication of JP2022516199A publication Critical patent/JP2022516199A/ja
Publication of JP2022516199A5 publication Critical patent/JP2022516199A5/ja
Priority to JP2024219524A priority Critical patent/JP7825894B2/ja
Application granted granted Critical
Publication of JP7630173B2 publication Critical patent/JP7630173B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539453A 2019-01-07 2020-01-03 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物 Active JP7630173B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024219524A JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201910015257 2019-01-07
CN201910015257.7 2019-01-07
CN201911412811.1A CN111407881A (zh) 2019-01-07 2019-12-31 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物
CN201911412811.1 2019-12-31
PCT/CN2020/070299 WO2020143548A1 (zh) 2019-01-07 2020-01-03 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024219524A Division JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Publications (3)

Publication Number Publication Date
JP2022516199A JP2022516199A (ja) 2022-02-24
JP2022516199A5 true JP2022516199A5 (https=) 2022-12-19
JP7630173B2 JP7630173B2 (ja) 2025-02-17

Family

ID=71485079

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021539453A Active JP7630173B2 (ja) 2019-01-07 2020-01-03 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物
JP2024219524A Active JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024219524A Active JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Country Status (7)

Country Link
US (1) US20220096599A1 (https=)
EP (1) EP3909599A4 (https=)
JP (2) JP7630173B2 (https=)
CN (1) CN111407881A (https=)
AU (1) AU2020206381B2 (https=)
CA (1) CA3125377A1 (https=)
WO (1) WO2020143548A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236430B (zh) * 2024-04-07 2025-08-26 中国人民解放军总医院第六医学中心 一种修复肿瘤治疗心肌损伤的药物组合物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
US20010041869A1 (en) 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
US6589229B1 (en) 2000-07-31 2003-07-08 Becton, Dickinson And Company Wearable, self-contained drug infusion device
CN1498656A (zh) * 2002-11-08 2004-05-26 上海泽生科技开发有限公司 神经调节蛋白用于心肌梗死治疗的方法和组合物
AU2002304965A1 (en) * 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US7128727B2 (en) 2002-09-30 2006-10-31 Flaherty J Christopher Components and methods for patient infusion device
US7144384B2 (en) 2002-09-30 2006-12-05 Insulet Corporation Dispenser components and methods for patient infusion device
US20050065760A1 (en) 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
US9233203B2 (en) 2005-05-06 2016-01-12 Medtronic Minimed, Inc. Medical needles for damping motion
CN101394861A (zh) * 2005-12-30 2009-03-25 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
ES2530526T3 (es) * 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
CN103768582A (zh) * 2006-12-29 2014-05-07 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
RU2497532C2 (ru) * 2008-12-03 2013-11-10 Эморсайт, Инк. Композиции, улучшающие перфузию в области инфаркта и способы восстановления сосудистого повреждения
ES2748886T3 (es) * 2009-06-09 2020-03-18 Zensun Shanghai Science & Tech Co Ltd Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
JP6096262B2 (ja) * 2009-08-25 2017-03-15 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) * 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) * 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
CN103127579B (zh) 2011-11-21 2017-06-16 上海泽生科技开发股份有限公司 便携式注射泵的驱动系统
AU2012392119B2 (en) * 2012-10-08 2018-07-26 Zensun (Shanghai) Science & Technology, Co. Ltd. Compositions and methods for treating heart failure in diabetic patients
JP6542678B2 (ja) * 2013-03-06 2019-07-10 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはその断片の治療的投与の方法
EP3895724B1 (en) * 2013-05-22 2025-06-25 Zensun (Shanghai) Science and Technology, Co., Ltd. Extended release of neuregulin for treating heart failure
CN111407882A (zh) * 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
WO2017053794A1 (en) * 2015-09-25 2017-03-30 Sawyer Douglas B Methods for treating cardiac injury
US11820981B2 (en) * 2016-09-14 2023-11-21 Agency For Science, Technology And Research Modulation of TJP1 expression to regulate regeneration of heart cells
JP2017125032A (ja) * 2017-02-20 2017-07-20 ゼンスン（シャンハイ）サイエンス アンド テクノロジー カンパニー リミテッド 糖尿病患者における心不全の治療用組成物

Similar Documents

Publication Publication Date Title
JP2023503309A5 (https=)
JP2023503303A5 (https=)
JP2022009090A5 (https=)
JP2023503071A5 (https=)
RU2012148710A (ru) Органическое соединение для применения при лечении рака печени
IT8922725A1 (it) Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
JP2024516363A5 (https=)
JP2024516795A5 (https=)
JP2022516199A5 (https=)
Vorakulpipat et al. Combination of advanced platelet-rich fibrin and pentoxifylline/tocopherol as a novel preventive option in osteoradionecrosis: a case report
JP2025060703A5 (https=)
WO2014129818A1 (ko) 당뇨병성 창상의 예방 또는 치료용 약학 조성물
Babaei et al. Sodium bicarbonate containing mouthwash for preventing radiotherapy-induced oral mucositis in patients with locally advanced head and neck cancer
CN104758304B (zh) 三七皂苷r1的医药用途
JOP20170044B1 (ar) تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو
JP2018522881A5 (https=)
JP2022504435A5 (https=)
Fusco Mouth care
Kokelj et al. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients
Petry et al. Medicinal herbs: answers and advice, part 1
CN105796543B (zh) U0126在制备治疗帕金森药物上的应用
Roboz Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia
JP2006522061A5 (https=)
CN106943415B (zh) 一种预防和治疗皮肤瘙痒的外用药物组合物及其制备方法和用途
CN108245534A (zh) 一种治疗口腔溃疡的中药